|
1
|
Kuhnen A: Genetic and environmental
considerations for inflammatory bowel disease. Surg Clin North Am.
99:1197–1207. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Vedamurthy A and Ananthakrishnan AN:
Influence of environmental factors in the development and outcomes
of inflammatory bowel disease. Gastroenterol Hepatol (N Y).
15:72–82. 2019.PubMed/NCBI
|
|
3
|
Scalavino V, Piccinno E, Giannelli G and
Serino G: Inflammasomes in intestinal disease: Mechanisms of
activation and therapeutic strategies. Int J Mol Sci.
25(13058)2024.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Centanni L, Bencardino S, D'Amico F, Zilli
A, Parigi TL, Allocca M, Danese S and Furfaro F: Targeting mucosal
healing in Crohn's disease: Efficacy of novel pathways and
therapeutic targets. Expert Opin Ther Targets. 28:963–978.
2024.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kohgo Y, Ashida T, Maemoto A and Ayabe T:
Leukocytapheresis for treatment of IBD. J Gastroenterol. 38 (Suppl
15):S51–S54. 2003.PubMed/NCBI
|
|
6
|
Deleu S, Becherucci G, Godny L, Mentella
MC, Petito V and Scaldaferri F: The key nutrients in the
mediterranean diet and their effects in inflammatory bowel disease:
A narrative review. Nutrients. 16(4201)2024.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Miao Z, Gu M, Raza F, Zafar H, Huang J,
Yang Y, Sulaiman M, Yan J and Xu Y: Isoliquiritin ameliorates
ulcerative colitis in rats through caspase 3/HMGB1/TLR4 dependent
signaling pathway. Curr Gene Ther. 24:73–92. 2024.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bseiso Y, Gammoh O, Alqudah M, Altaber S,
Qnais E, Wedyan M, Alqudah A and Alotaibi BS: Evaluating the
anti-inflammatory efficacy of a novel bipyrazole derivative in
alleviating symptoms of experimental colitis. Curr Mol Pharmacol.
17(e18761429333261)2024.PubMed/NCBI View Article : Google Scholar
|
|
9
|
da Silva LM: Perspectives on the role of
P21-activated kinase 1 (PAK1) in the intestinal anti-inflammatory
and antitumor potential of artepillin C. Curr Mol Pharmacol.
17(e260423216212)2024.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Davydov M and Krikorian AD:
Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (Araliaceae)
as an adaptogen: A closer look. J Ethnopharmacol. 72:345–393.
2000.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu KY, Wu YC, Liu IM, Yu WC and Cheng JT:
Release of acetylcholine by syringin, an active principle of
eleutherococcus senticosus, to raise insulin secretion in Wistar
rats. Neurosci Lett. 434:195–199. 2008.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yi JM, Hong SH, Kim JH, Kim HK, Song HJ
and Kim HM: Effect of Acanthopanax senticosus stem on mast
cell-dependent anaphylaxis. J Ethnopharmacol. 79:347–352.
2002.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Fujikawa T, Yamaguchi A, Morita I, Takeda
H and Nishibe S: Protective effects of Acanthopanax
senticosus Harms from Hokkaido and its components on gastric
ulcer in restrained cold water stressed rats. Biol Pharm Bull.
19:1227–1230. 1996.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Liu SM, Li XZ, Zhang SN, Yang ZM, Wang KX,
Lu F, Wang CZ and Yuan CS: Acanthopanax senticosus protects
structure and function of mesencephalic mitochondria in A mouse
model of Parkinson's disease. Chin J Integr Med. 24:835–843.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kawano Y, Tanaka M, Fujishima M, Okumura
E, Takekoshi H, Takada K, Uehara O, Abiko Y and Takeda H:
Acanthopanax senticosus Harms extract causes G0/G1 cell
cycle arrest and autophagy via inhibition of Rubicon in human liver
cancer cells. Oncol Rep. 45:1193–1201. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Takahashi Y, Tanaka M, Murai R,
Kuribayashi K, Kobayashi D, Yanagihara N and Watanabe N:
Prophylactic and therapeutic effects of Acanthopanax
senticosus Harms extract on murine collagen-induced arthritis.
Phytother Res. 28:1513–1519. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
17
|
Cooper HS, Murthy SN, Shah RS and
Sedergran DJ: Clinicopathologic study of dextran sulfate sodium
experimental murine colitis. Lab Invest. 69:238–249.
1993.PubMed/NCBI
|
|
18
|
Williams KL, Fuller CR, Dieleman LA,
DaCosta CM, Haldeman KM, Sartor RB and Lund PK: Enhanced survival
and mucosal repair after dextran sodium sulfate-induced colitis in
transgenic mice that overexpress growth hormone. Gastroenterology.
120:925–937. 2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
García-Díez E, López-Oliva ME,
Caro-Vadillo A, Pérez-Vizcaíno F, Pérez-Jiménez J, Ramos S and
Martín MÁ: Supplementation with a cocoa-carob blend, alone or in
combination with metformin, attenuates diabetic cardiomyopathy,
cardiac oxidative stress and inflammation in zucker diabetic rats.
Antioxidants (Basel). 11(432)2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Nauseef WM: The phagocyte NOX2 NADPH
oxidase in microbial killing and cell signaling. Curr Opin Immunol.
60:130–140. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Regmi SC, Park SY, Ku SK and Kim JA:
Serotonin regulates innate immune responses of colon epithelial
cells through Nox2-derived reactive oxygen species. Free Radic Biol
Med. 69:377–389. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hoffmann MH and Griffiths HR: The dual
role of reactive oxygen Species in autoimmune and inflammatory
diseases: Evidence from preclinical models. Free Radic Biol Med.
125:62–71. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Khor TO, Huang MT, Kwon KH, Chan JY, Reddy
BS and Kong AN: Nrf2-deficient mice have an increased
susceptibility to dextran sulfate sodium-induced colitis. Cancer
Res. 66:11580–11584. 2006.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bamba S, Andoh A, Ban H, Imaeda H, Aomatsu
T, Kobori A, Mochizuki Y, Shioya M, Nishimura T, Inatomi O, et al:
The severity of dextran sodium sulfate-induced colitis can differ
between dextran sodium sulfate preparations of the same molecular
weight range. Dig Dis Sci. 57:327–334. 2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Xiao YT, Yan WH, Cao Y, Yan JK and Cai W:
Neutralization of IL-6 and TNF-α ameliorates intestinal
permeability in DSS-induced colitis. Cytokine. 83:189–192.
2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Menghini P, Corridoni D, Buttó LF, Osme A,
Shivaswamy S, Lam M, Bamias G, Pizarro TT, Rodriguez-Palacios A,
Dinarello CA and Cominelli F: Neutralization of IL-1α ameliorates
Crohn's disease-like ileitis by functional alterations of the gut
microbiome. Proc Natl Acad Sci USA. 116:26717–26726.
2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kim DJ, Kim KS, Song MY, Seo SH, Kim SJ,
Yang BG, Jang MH and Sung YC: Delivery of IL-12p40 ameliorates
DSS-induced colitis by suppressing IL-17A expression and
inflammation in the intestinal mucosa. Clin Immunol. 144:190–199.
2012.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zeng Z, Lin H, Jiang M, Yuan J, Li X, Jia
Y, Yang L and Zhang H: Anti-TNFα in inflammatory bowel disease:
From originators to biosimilars. Front Pharmacol.
15(1424606)2024.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ott A, Tutdibi E, Goedicke-Fritz S, Schöpe
J, Zemlin M and Nourkami-Tutdibi N: Serum cytokines MCP-1 and GCS-F
as potential biomarkers in pediatric inflammatory bowel disease.
PLoS One. 18(e0288147)2023.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Huang L, Zhao H, Huang B, Zheng C, Peng W
and Qin L: Acanthopanax senticosus: Review of botany,
chemistry and pharmacology. Pharmazie. 66:83–97. 2011.PubMed/NCBI
|
|
32
|
Jung CH, Jung H, Shin YC, Park JH, Jun CY,
Kim HM, Yim HS, Shin MG, Bae HS, Kim SH and Ko SG: Eleutherococcus
senticosus extract attenuates LPS-induced iNOS expression through
the inhibition of Akt and JNK pathways in murine macrophage. J
Ethnopharmacol. 113:183–187. 2007.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kawano Y, Watanabe N, Nishiyama M, Ohmura
T, Mihara H, Ono K, Tanaka M, Sato Y, Tomonari T, Takeda H and
Takayama T: Feasibility and safety of food containing
Acanthopanax senticosus for treating patients with
cancer-related fatigue. Palliat Med Rep. 5:381–386. 2024.PubMed/NCBI View Article : Google Scholar
|
|
34
|
He S, Zhang T, Wang YY, Yuan W, Li L, Li
J, Yang YY, Wu DM and Xu Y: Isofraxidin attenuates dextran sulfate
sodium-induced ulcerative colitis through inhibiting pyroptosis by
upregulating Nrf2 and reducing reactive oxidative species. Int
Immunopharmacol. 128(111570)2024.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhang H, Gu H, Jia Q, Zhao Y, Li H, Shen
S, Liu X, Wang G and Shi Q: Syringin protects against colitis by
ameliorating inflammation. Arch Biochem Biophys.
680(108242)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhang P, Jiao H, Wang C, Lin Y and You S:
Chlorogenic acid ameliorates colitis and alters colonic microbiota
in a mouse model of dextran sulfate sodium-induced colitis. Front
Physiol. 10(325)2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lee CH, Koh SJ, Radi ZA and Habtezion A:
Animal models of inflammatory bowel disease: Novel experiments for
revealing pathogenesis of colitis, fibrosis, and colitis-associated
colon cancer. Intest Res. 21:295–305. 2023.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Bábíčková J, Tóthová Ľ, Lengyelová E,
Bartoňová A, Hodosy J, Gardlík R and Celec P: Sex differences in
experimentally induced colitis in mice: A role for estrogens.
Inflammation. 38:1996–2006. 2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Goodman WA, Havran HL, Quereshy HA, Kuang
S, De Salvo C and Pizarro TT: Estrogen receptor α loss-of-function
protects female mice from DSS-induced experimental colitis. Cell
Mol Gastroenterol Hepatol. 5:630–633.e1. 2017.PubMed/NCBI View Article : Google Scholar
|
